Current Issue
Volumes and Issues
For Authors
Manuscript Guidelines
Review Process
Conflict of Interest
Copyright
About the Journal
Editorial Board
Aim and Scope
Policy and Ethical Guidelines
Promotion of the Journal
Print-Version Subscription
Publisher and Contact Information
Contact Information
Sign in
REVIEW PAPER
ASSESSMENT OF CENTRAL AUDITORY PROCESSING DISORDER IN CHILDREN AND ADOLESCENTS TREATED WITH METHYLPHENIDATE DUE TO ATTENTION DEFICIT DISORDER: SYSTEMATIC REVIEW
1
Posgrado, Escuela Superior de Medicina, Instituto Politécnico Nacional, México, Mexico
2
Servicio de Audiología, Hospital del Niño Poblano, Mexico
3
Subdirección de Medicina de Rehabilitación, Instituto Nacional de Rehabilitación “Luis Guillermo Ibarra Ibarra”, Mexico
4
Servicio de Audiología, Instituto Nacional de Rehabilitación “Luis Guillermo Ibarra Ibarra”, Mexico
A - Research concept and design; B - Collection and/or assembly of data; C - Data analysis and interpretation; D - Writing the article; E - Critical revision of the article; F - Final approval of article;
Submission date: 2020-04-22
Final revision date: 2020-05-26
Acceptance date: 2020-06-03
Publication date: 2020-08-24
Corresponding author
José Alfredo Sierra-Ramírez
Posgrado, Escuela Superior de Medicina, Instituto Politécnico Nacional, México, email: alfsierra08@yahoo.com
Posgrado, Escuela Superior de Medicina, Instituto Politécnico Nacional, México, email: alfsierra08@yahoo.com
J Hear Sci 2020;10(2):20-26
KEYWORDS
TOPICS
ABSTRACT
Background:
Improvement in central auditory processing (CAP) test results has been reported in children with attention deficit disorder (ADD) who have been treated with methylphenidate (MPH).
Objective:
To determine the effect of MPH on CAP tests in school-aged children and adolescents with ADD, with or without hyperactivity.
Methods:
A systematic review was carried out following the Prisma methodology in The Cochrane Library, Medline, Embase, and Lilacs data bases. Randomized (RCT) and non-randomized (NRCT) clinical trials were included, involving male and female patients between 6 and 18 years old, with normal audition and intelligence and diagnosed with ADD; they were given MPH treatment and the results of CAP tests were compared to placebo or non-MPH treatment.
Results:
Five studies (two RCTs and three NRCTs) reported on 187 participants of both sexes, between 6 and 15 years old, of which 135 individuals met the diagnostic criteria for ADD and 44 presented ADD with central auditory processing (CAP) disorder, with 52 individuals used as controls. MPH treatment produced an increase in the performance of the speech-in-noise test (0.38 SMD [95% CI 0.11 to 0.66] [Z = 2.7, p = 0.007]), staggered spondaic words test (0.35 SMD [95% CI 0 to 0.69] [Z = 1.95, p = 0.05]) and filtered word test, frequency pattern test, and phonemic synthesis test (0.35 SMD [95% CI 0.01 to 0.68] [Z = 2.03, p = 0.04]. Also, continuous performance tests showed a decrease in the number of errors and inattentions (–0.77 SMD [95% CI –1.17 to –0.37] [Z = 3.79, p = 0.0002]) concerning the control group. The evidence was consistent, accurate, and with low heterogeneity.
Conclusions:
MPH has a significant and favorable effect on the CAP tests of children and adolescents with ADD.
Improvement in central auditory processing (CAP) test results has been reported in children with attention deficit disorder (ADD) who have been treated with methylphenidate (MPH).
Objective:
To determine the effect of MPH on CAP tests in school-aged children and adolescents with ADD, with or without hyperactivity.
Methods:
A systematic review was carried out following the Prisma methodology in The Cochrane Library, Medline, Embase, and Lilacs data bases. Randomized (RCT) and non-randomized (NRCT) clinical trials were included, involving male and female patients between 6 and 18 years old, with normal audition and intelligence and diagnosed with ADD; they were given MPH treatment and the results of CAP tests were compared to placebo or non-MPH treatment.
Results:
Five studies (two RCTs and three NRCTs) reported on 187 participants of both sexes, between 6 and 15 years old, of which 135 individuals met the diagnostic criteria for ADD and 44 presented ADD with central auditory processing (CAP) disorder, with 52 individuals used as controls. MPH treatment produced an increase in the performance of the speech-in-noise test (0.38 SMD [95% CI 0.11 to 0.66] [Z = 2.7, p = 0.007]), staggered spondaic words test (0.35 SMD [95% CI 0 to 0.69] [Z = 1.95, p = 0.05]) and filtered word test, frequency pattern test, and phonemic synthesis test (0.35 SMD [95% CI 0.01 to 0.68] [Z = 2.03, p = 0.04]. Also, continuous performance tests showed a decrease in the number of errors and inattentions (–0.77 SMD [95% CI –1.17 to –0.37] [Z = 3.79, p = 0.0002]) concerning the control group. The evidence was consistent, accurate, and with low heterogeneity.
Conclusions:
MPH has a significant and favorable effect on the CAP tests of children and adolescents with ADD.
REFERENCES (23)
1.
American Speech-Language-Hearing Association (2005). (Central) auditory processing disorders [Technical Report]. Available from www.asha.org/policy.
2.
Jerger J, Musick F. Report of the Consensus Conference on the Diagnosis of Auditory Processing Disorders in School-Aged Children. J Am Acad Audiol, 2000; 11(9): 467–74.
3.
Cormier E. Attention deficit/hyperactivity disorder: a review and update. J Pediatr Nurs, 2008; 23(5): 345–57.
4.
Palfery TD, Duff D. Central auditory processing disorders: review and case study. Axone, 2007; 28(3): 20–3.
5.
Del Zoppo C, Sanchez L, Lind C. A long-term follow-up of children and adolescents referred for assessment of auditory processing disorder. Int J Audiol, 2015; 54(6): 368–75.
6.
Shaw M, Hodgkins P, Caci H, et al. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med, 2012; 10: 99.
7.
Yew SGK, O’Kearney R. Language difficulty at school entry and the trajectories of hyperactivity–inattention problems from ages 4 to 11: evidence from a population-representative cohort study. J Abnorm Child Psychol, 2017; 45: 1105–18.
8.
Purvis KL, Tannock R. Language abilities in children with attention deficit hyperactivity disorder, reading disabilities, and normal controls. J Abnorm Child Psychol, 1997; 25: 133–44.
9.
Ptok M, Buller N, Schwemmle C, Bergmann C, Lüerßen K. Auditive Verarbeitungs- und Wahrnehmungsstörungen versus Aufmerksamkeitsstörungen mit/ohne Hyperaktivität. HNO, 2006; 54: 405–14.
10.
Tillery KL, Katz J, Keller WD. Effects of methylphenidate (Ritalin) on auditory performance in children with attention and auditory processing disorders. J Speech Lang Hear Res, 2000; 43(4): 893–901.
11.
Keith RW, Engineer P. Effects of methylphenidate on the auditory processing abilities of children with attention deficit-hyperactivity disorder. J Learn Disabil, 1991; 24(10): 630–6.
12.
Riccio CA, Hynd GW, Cohen MJ, Hall J, Molt L. Comorbidity of central auditory processing disorder and attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry, 1994; 33(6): 849–57.
13.
Storebø OJ, Pedersen N, Ramstad E, et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents: assessment of adverse events in non‐randomised studies. Cochrane Database Syst Rev, 2018; 5: CD012069. 14. Yalçinkaya F, Keith R. Understanding auditory processing disorders. Turk J Pediatr, 2008; 50: 101–5.
14.
Lanzetta-Valdo BP, Oliveira GA, Ferreira JT, Palacios EM. Auditory processing assessment in children with attention deficit hyperactivity disorder: an open study examining methylphenidate effects. Int Arch Otorhinolaryngol, 2017; 21(1): 72–8.
15.
Steinau S. Diagnostic criteria in attention deficit hyperactivity disorder: changes in DSM 5. Front Psychiatry, 2013; 4: 49.
16.
Emanuel DC. The auditory processing battery: survey of common practices. J Am Acad Audiol, 2002; 13(2): 93-117; Quiz 118–9.
17.
Cook JR, Mausbach T, Burd L, et al. A preliminary study of the relationship between central auditory processing disorder and attention deficit disorder. J Psychiatry Neurosci, 1993; 18: 130–7.
18.
Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction: GRADE evidence profiles and summary of findings tables. J Clin Epidemiol, 2011; 64(4): 383–94.
19.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.
20.
Cavadas M, Pereira LD, Mattos P. Efeito do metilfenidato no processamento auditivo em crianças e adolescentes com transtorno do deficit de atenção/hiperatividade. Arq Neuro-Psiquiatr, 2007; 65(1): 138–43.
21.
Huss M, Duhan P, Gandhi P, Chen C-W, Spannhuth C, Kumar V. Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity. Neuropsychiatr Dis Treat, 2017; 13: 1741–51.
22.
Weiss D, Dempsey JJ. Performance of bilingual speakers on the English and Spanish versions of the Hearing in Noise Test (HINT). J Am Acad Audiol, 2008; 19: 5–17.
23.
Peñaloza-López YR, Olivares García M del R, Jiménez de la Sancha S, García-Pedroza F, Pérez Ruiz SJ. Procesos centrales de la audición evaluados en español en escolares con dislexia y controles. Pruebas de fusión binaural y de palabras filtradas. Acta Otorrinolaringol Esp, 2009; 60(6): 415–21.
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
